top of page

Biomimetic microsystems including organ-on-chip platforms

The cellular microenvironment regulates cell behavior and functions. Mimicking this microenvironment in vitro is very challenging both studying physiology and pathology. From the perspective of physiology, microfluidic platforms are developed which modeled the structure and function of human organs, particularly to predict drug safety in humans rapidly and effectively. More recently, disease modeling using organ-on-chip platforms to recapitulate the tissue functions at organ level has been utilized to have a deeper understanding of various diseases. Although animal models have been used to follow up critical diseases, it is often difficult to simulate these models to human physiology. Hence, our lab focused on the convergence of life sciences, engineering, and basic sciences in order to mimic physiological systems of biological organs such as the brain, liver and lung in vitro.

Various biophysicochemical factors as well as implantable materials causing immune reactions can be introduced into organ-on-a-chip platforms to study metabolic and systemic effects. In order to study this concept, our principal investigator, Prof. Yesil-Celiktas, has been involved in a project, where the aim was to develop strategies and solutions to validate the foreign body response (FBR), representing one of the most critical challenges in medical field. Developed FBR‐on‐a‐chip (FBROC) showed a potential to expand the studies of personalized FBR on vast categories according to the proof‐of‐concept experiments (Sharifi et al., 2019).

Resim1.jpg

and independent breast cancer cells in a butterfly shaped microfluidic chip allowing the cultivation of both cancerous and healthy mammary cells. Related data have been presented via a review (Yildiz-Ozturk & Yesil-Celiktas, 2015) and a research paper (Yildiz-Ozturk et al., 2017).

Recent studies on disease modeling using organ-on-chip platforms granted by TUBITAK are still ongoing.

 

Apart from these, we have conducted an extensive research in the area of biocatalytic conversions in microfluidic devices using sol-gel technology as an immobilization tool, and mathematical modeling was employed to create a better understanding of transport phenomena. A review (Yesil-Celiktas, 2014) and two papers (Akay et al., 2017; Kazan et al., 2017) have been published. Through a bilateral project, three PhD and four MSc grants were secured.

Our previous works on lung cancer-on-a-chip development provided informative data regarding the effects of some potential drug molecules. We have also investigated the effect of an anticancer compound onestrogen-dependent     

Ege University
Department of Bioengineering

35040 Bornova-Izmir/TURKEY

bottom of page